- Home
- / TISSIUM
TISSIUM
Total Funding
$81.8 M
Revenue
€8.8 M
FY, 2023
TISSIUM Summary
Company Summary
- Overview
- TISSIUM (formerly known as Gecko Biomedical) is a company that develops biomorphic programmable polymers. Its products include tissue sealants, fixation solutions, surgical scaffolds, and drug-eluting solutions designed for tissue reconstruction across different medical fields.
- Type
- Private
- Status
- Active
- Founded
- 2013
- HQ
- Paris, FR | view all locations
- Website
- https://tissium.com/
- Cybersecurity rating
Table of Contents
Key People
Maria Pereira, Co-Founder, Chief Innovation Officer
Hunt Henrie, Chief Business Officer
Jeff Karp, Board Member
LocationsView all
3 locations detected
Paris, Île-de-France HQ
France
74 rue du Faubourg Saint-Antoine
Cambridge, MA
United States
245 Main St, 2nd Floor
Roncq, Hauts-de-France
France
2, rue Pierre-Antoine Delahousse
TISSIUM Financials
Summary Financials
- Revenue (FY, 2023)
- €8.8M
- Net income (FY, 2023)
- (€27.3M)
- Cash (FY, 2023)
- €2.6M
- EBIT (FY, 2023)
- (€29.3M)